EU H2020 Project "SYMPTOMA (Symptoma, Better Diagnosis for Patients with Rare and Complex Diseases)": description, partecipants, costs and EC-fundings

#	Pagina
attuale pagina	/open-h2020/projects/218651/index.html
-1	/open-h2020/per-topic/ecoxy/list/index.html
-2	/open-h2020/per-topic/linux/list/index.html
-3	/open-consip/fornitori/2021/profilo-02156720902/index.html
-4	/open-h2020/projects/218266/index.html

Symptoma project word cloud

Explore the words cloud of the Symptoma project. It provides you a very rough idea of what is the project "Symptoma" about.

750 dealing solution spot unacceptable deaths proceeded err symptoma care misdiagnosis inaccurate errors sorted willingness total medicine free 446 ranging wasted solving spent accuracy com business budgets billion diagnoses decades pilot attain lives blind customers barriers wait first capitalize receive causes don globally learning list diagnosis 40 10 settings had symptoms competitors demonstrated right asking health million save intelligence satisfied cognitive mission decision continue search paradigm quality societal outdone harm suffer patients leaves unmet 3 delayed rate counteracting diagnostic overcoming questions overwhelm human enter healthcare advantage reducing delivering cognitively persist misdiagnoses demand tools diseases language deep doctors technological matching rare opportunity competitive engine time pushing 20k devastating patient pay companies probability profit 22 shown bar 30

Project "Symptoma" data sheet

The following table provides information about the project.

Coordinator	SYMPTOMA GMBH Organization address address: NEUHOFEN 5 city: ATTERSEE postcode: 4864 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	Austria [AT]
Project website	https://www.symptoma.com
Total cost	2˙282˙000 €
EC max contribution	1˙597˙400 € (70%)
Programme	1. H2020-EU.3. (PRIORITY 'Societal challenges) 2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs) 3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
Code Call	H2020-SMEInst-2018-2020-2
Funding Scheme	SME-2
Starting year	2018
Duration (year-month-day)	from 2018-09-01 to 2020-08-31

#	participants	country	role	EC contrib. [€]
1	SYMPTOMA GMBH	AT (ATTERSEE)	coordinator	1˙597˙400.00

SYMPTOMA GMBH

AT (ATTERSEE)

coordinator

1˙597˙400.00

Project objective

'OUR MISSION is to save 1.5 million lives globally each year by delivering the right diagnosis. SOCIETAL PROBLEM: To err is human. But in medicine, errors cost lives. 'The delivery of health care has proceeded for decades with a blind spot: Diagnostic errors - inaccurate or delayed diagnoses - persist throughout all settings of care and continue to harm an unacceptable number of patients.' - Institute of Medicine. Studies have shown a devastating rate of misdiagnoses ranging from 10 to 40%. Diagnostic errors cause 10% of patient deaths. 20k diseases cognitively overwhelm doctors. Only 3% of doctors are satisfied with existing research tools. Misdiagnoses account for €446 billion in wasted costs in the EU and $750 billion in the US. Solving misdiagnosis could free up 30% of total healthcare budgets globally. Patients with rare diseases suffer most. 22 of 30 million patients with rare diseases in the EU don’t have their diagnosis yet, and 8 million had to wait 10 years in average. This leaves doctors and patients with a high unmet need. SOLUTION: Symptoma.com is a free search engine for diseases. Users enter symptoms and receive a list of matching causes – sorted by probability. COMPETITIVE ADVANTAGE: Symptoma’s diagnostic accuracy has outdone all competitors’ raising the bar for this field as first and only viable solution. We have demonstrated (1) technological success, (2) high demand, and (3) willingness to pay for our solution operating at a profit with pilot customers. OUR GOAL is to improve diagnostic quality while reducing cost and time spent. We will attain this goal by pushing Symptoma to the next level by (deep) learning from search behaviour, asking questions (cognitive intelligence), and overcoming language barriers. This project is the first step towards a new paradigm of diagnostic decision making. We will fully capitalize on the business opportunity counteracting misdiagnoses for companies dealing with rare diseases.'

List of deliverables.
D2.2 Release question sequences derived from deep learning algorithms.	Demonstrators, pilots, prototypes	2020-01-14 16:40:45

Publications

List of publications.
year	authors and title	journal	last update
2019	DGIM Querdenker-Preis published pages: 1085-1085, ISSN: 0012-0472, DOI: 10.1055/a-0954-8989	DMW - Deutsche Medizinische Wochenschrift 144/15	2019-11-22
2019	J. Nateqi, S. Lin, H. Krobath, S. Gruarin, T. Lutz, T. Dvorak, A. Gruschina, R. Ortner Vom Symptom zur Diagnose â€“ Tauglichkeit von Symptom-Checkern published pages: 334-342, ISSN: 0017-6192, DOI: 10.1007/s00106-019-0666-y	HNO 67/5	2019-11-18

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SYMPTOMA" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SYMPTOMA" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)